Welcome to our dedicated page for Curaleaf Hldgs SEC filings (Ticker: CURLF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Curaleaf Holdings, Inc. (CURLF) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a foreign issuer. Curaleaf files reports on Form 6-K under the Securities Exchange Act of 1934, and indicates that it uses Form 40-F and a registration statement on Form F-10 for certain filings. These documents include press releases, unaudited condensed interim consolidated financial statements, management’s discussion and analysis, and officer certifications.
Recent Form 6-K filings for Curaleaf reference its principal executive office in Vancouver, British Columbia, and attach exhibits such as quarterly financial statements, MD&A, CEO and CFO certifications of interim filings, and press releases. One Form 6-K identifies Exhibit 99.1 as unaudited condensed interim consolidated financial statements and MD&A for the three and nine months ended September 30, 2025, along with related certifications and a press release announcing the results.
Curaleaf also uses Form 6-K to furnish material corporate announcements, including press releases about its proposed arrangement to continue from British Columbia to Delaware, the upsizing of its revolving credit facility with Needham Bank, and transaction-related updates concerning The Cannabist Company’s Virginia assets. These filings provide detail on capital structure, borrowing arrangements, and strategic decisions.
On Stock Titan, Curaleaf’s filings are updated in line with submissions to the SEC’s EDGAR system. AI-powered tools can help users quickly understand the key points in lengthy exhibits, such as segment revenue breakdowns, non-GAAP financial measures definitions, and discussions of cash flow and debt. Users interested in foreign issuer reporting, cannabis sector financials, or CURLF’s corporate structure can review the sequence of Form 6-K and related documents to follow how the company presents its financial condition, results of operations and significant corporate events over time.
Curaleaf Holdings, Inc. is issuing US$500,000,000 of 11.50% Senior Secured Notes due February 18, 2029 under a Fourth Supplemental Indenture. The notes pay 11.50% interest semi-annually in U.S. dollars, starting August 18, 2026, and may be issued in additional tranches on the same terms.
Before August 18, 2027, Curaleaf can redeem up to 35% of the notes at par plus 100% of the coupon and accrued interest using net cash from qualifying equity offerings. From August 18, 2027, the notes are redeemable at 105.750% of principal, and at 100.000% from February 18, 2028 onward, plus accrued interest.
Curaleaf Holdings, Inc. filed its Annual Report on Form 40-F for the fiscal year ended
The filing names PKF O'Connor Davies, LLP and related PKF firms as independent auditors, lists aggregate auditor fees for 2025 and 2024, and includes an exhibit index with the Annual Information Form, audited financials, officer certifications and an earnings release dated
Curaleaf Holdings has closed a private placement of
The company redeemed its previously outstanding
Curaleaf Holdings, Inc. is postponing its previously planned special shareholder meeting to approve a proposed arrangement that includes continuing the company out of British Columbia and domestication in Delaware in the United States. The special meeting will now be combined with Curaleaf’s annual general meeting, expected in the second quarter of 2026.
The company believes holding a combined annual and special meeting will encourage greater shareholder participation, streamline approvals and use resources more efficiently. Curaleaf plans to announce the new meeting date later and will send shareholders an Information Circular, which will also be filed on SEDAR+ and with the SEC.
Curaleaf Holdings, Inc. has scheduled the release of its fourth quarter and full year 2025 financial and operating results for after market close on February 26, 2026. Management will discuss the results on a conference call and webcast that day at 5:00 p.m. ET, followed by a question-and-answer session.
Curaleaf Holdings, Inc. released preliminary, unaudited results for Q4 2025 and announced strategic exits from its hemp business and the state of Missouri. Net revenue for Q4 2025 excluding these discontinued operations is expected to be at least $330 million, implying approximately 4% sequential growth from Q3 2025 net revenue of $317.8 million and about 1% growth versus Q4 2024 net revenue of $327.8 million, above the prior guidance of low single digit growth.
Fourth quarter adjusted gross profit margin excluding the discontinued businesses is anticipated to be about 48.5%, in line with Q4 2024, and full year 2025 adjusted gross margin is expected to be around 50%. Management is discontinuing the hemp division following U.S. federal legislation reducing permitted hemp-derived THC content to 0.3% and exiting Missouri due to sub-scale operations; together these units contributed roughly $2 million of revenue across Q3 and Q4 2025. The company also highlighted plans to complete refinancing of its senior secured notes due December 2026 and expects to release full Q4 and full-year 2025 results by early March.